Blocked from discussing new research, Dr Kevin Hall said he doubted if he could continue to freely conduct ‘unbiased science’ ...

Research estimates that pressure injuries (otherwise known as bedsores) are attributable to approximately 60,000 deaths per ...

Pearsanta has secured approval from WCG Clinical’s IRB to begin a clinical trial of the blood-based Mitomic Endometriosis ...

GeneDx has announced its intention to acquire Fabric Genomics, a move that positions it to advance in the field of genomic ...

Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify Vitamin D levels in blood ...

Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...

The US Food and Drug Administration (FDA) has granted marketing authorisation for ActiveProtective Technologies’ (APT) Tango ...

Verafeye is a four-dimensional (4D), ultrasound-based cardiac visualisation and navigation platform that generates a ...

Cadwell Industries has made a strategic investment in the Australian company Seer Medical, which specialises in epilepsy ...

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

During a speech at the FDA, the HHS secretary accused staff of becoming "sock puppets" of the industry they regulate. Last ...

Researchers from Weill Cornell Medicine (WCM) and New York Genome Center (NYGC), US, have identified an “accurate” and ...